Trials / Completed
CompletedNCT04860778
An Open-label, Exploratory Study to Investigate the Efficacy of BDNF Essentials® on Cognition
An Open-label, Exploratory Study to Investigate the Efficacy of BDNF Essentials® on Cognition in a Healthy Adult Population With Self-reported Memory Complaints
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Researched Nutritionals LLC · Industry
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- Accepted
Summary
The objective of this open-label, exploratory study is to investigate the efficacy of BDNF Essentials® on cognition in a healthy adult population with self-reported memory complaints. As there is a dearth of available literature on BDNF in this study population, the current study is designed to understand the role of BDNF to inform potential future studies.
Detailed description
The objective of this open-label, exploratory study is to investigate the efficacy of BDNF Essentials® on cognition in a healthy adult population with self-reported memory complaints. As there is a dearth of available literature on BDNF in this study population, the current study is designed to understand the role of BDNF to inform potential future studies. The study population represents a target group of individuals who would benefit from safe and efficacious nutraceuticals for the support of cognitive function. This transitional stage from normal cognition to cognitive impairment is viewed as an opportune window for intervention. This population of participants is being recruited to expand on previously published work on these individual ingredients while limiting confounding variables that could influence outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | BDNF Essentials | Participants will take two capsules, twice daily with water for 84 days. |
Timeline
- Start date
- 2021-04-27
- Primary completion
- 2021-09-10
- Completion
- 2021-09-10
- First posted
- 2021-04-27
- Last updated
- 2022-04-28
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT04860778. Inclusion in this directory is not an endorsement.